SLC30A3 and Alzheimer disease: Interestingly, Bjorklund et al. (2012) found that in brains exhibiting AD neuropathology, ZnT3 levels were lowest in those patients who received a diagnosis of AD, while those who did not receive a diagnosis had ZnT3 levels similar to those of healthy controls.